Medical device and MedTech insights, news, tips and more

Cardio Flow, Inc., Announces FDA Clearance for FreedomFlow® Peripheral Guidewire, and their First Commercial Case Completed in U.S.

June 7, 2022


Cardio Flow, Inc., a medical device company and developer of minimally invasive peripheral vascular devices to treat peripheral artery disease (PAD), announced it recently received U.S. Food and Drug Administration (FDA) clearance for the company’s FreedomFlow® Peripheral Guidewire.

The FreedomFlow guidewire is stainless steel core-to-tip design with a fixed distal-spring coil which was developed to provide exceptional support for diagnostic and therapeutic devices used in treating plaque blockages in arteries both above and below the knee.

The new guidewire features a silicone-coated spring coil along with a silicone coating on the distal 200cm that eases the crossing of difficult blockages. Furthermore, the 0.014-inch core-to-tip design provides interventionists superior torque transmission and precise control when delivering therapeutic devices.

First Commercial Case

This week Dr. Jihad Mustapha, MD, FACC, FSCAI, the Director of Endovascular Interventions at Advanced Cardiac & Vascular Centers for Amputation Prevention in Grand Rapids, MI, completed the first commercial case with the new guidewire on a patient presenting with complex multi-vessel disease with blockages below the knee, requiring a pedal loop.

Dr. Mustapha was impressed with the trackability and versatility of the FreedomFlow guidewire, noting, “I was able to deliver three PTA balloons, one IVUS catheter, and a therapeutic device across the single guidewire—all glided easily along the FreedomFlow wire. This new product has the potential to save time and costs in the endovascular lab, given its versatility in crossing occlusions and ability to deliver multiple interventional devices on a single guidewire.”

Scott Kraus, Vice President of Sales & Market for Cardio Flow, commented, “Cardio Flow is encouraged by the initial feedback from Dr. Mustapha, who is a recognized leader in the treatment of PAD and critical limb ischemia (CLI). We look forward to bringing this advancement in guidewire technology to our U.S. customers with a limited market release, followed by expanded commercial efforts in 2022.”

About Cardio Flow, Inc.

Cardio Flow, Inc., is a privately held medical device company that develops minimally invasive peripheral vascular products. The FreedomFlow® Peripheral Guidewire is the first of several devices in development to treat Peripheral Artery Disease (PAD). See for more information.

About Advanced Cardiac & Vascular Centers© (ACV)

Launched in February 2018, Advanced Cardiac & Vascular Centers for Amputation Prevention provides highly personalized and comprehensive cardiac, vascular, and vein care. Co-founded by Dr. Jihad Mustapha and Dr. Fadi Saab, ACV Centers has a special concentration on treating peripheral artery disease and the complications of critical limb ischemia. For further information, visit

See Full Press Release at the Source: Cardio Flow, Inc., Announces FDA Clearance for FreedomFlow® Peripheral Guidewire, plus First Commercial Case Completed in U.S.

Press Release by: Cardio Flow, Inc.

Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 17 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.